OMDA
Omada Health, Inc.
Healthcare · Health Information Services · NMS
$17.93
Data: 2026-05-28
✓ ETHICAL PASS

Unknown MOAT
HIGH
Data Confidence: 85.7%
Key Metrics

How this company measures up on the fundamentals that matter

Market Cap
$979M
Total market value of the company
Trailing P/E
N/A
Forward P/E
34.54
Based on estimated future earnings — lower means cheaper
Rev Growth
+42.0%
Year-over-year revenue change
Profit Margin
-2.2%
How much profit the company keeps from each dollar of revenue
ROE
-4.3%
Return on equity — how efficiently it uses shareholder money
Analyst Target
$22.50
+25% from current price — median analyst estimate
Recommendation
BUY
Consensus view from 12 analysts covering this stock
About Omada Health, Inc.

Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.

https://www.omadahealth.com

Country: United States Employees: 943 Industry: Health Information Services
Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity
PASS
Core business does not involve prohibited activities
Debt Ratio
0.0% N/A
Debt must be below 33% of total assets
Cash Ratio
0.0% N/A
Interest-bearing cash below 33% of assets
Receivables
0.0% N/A
Receivables below 49% of assets
Revenue Purity
0.0% PASS
Non-compliant revenue below 5% — any excess requires purification
Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime
ACCUMULATION
Smart money appears to be building positions quietly
Sharpe Ratio
-0.076
Returns do not compensate for the risk — negative edge
Kelly Fraction
-0.0204
No positive edge detected — the data suggests staying out
Calmar Ratio
-0.390
Drawdown risk outweighs the returns — higher risk profile
Annual Return
-23.1%
Historical annualised return based on price data
Max Drawdown
-59.2%
Largest peak-to-trough decline — the worst it has been
HMM State
SIDEWAYS
Price consolidating — no clear directional bias
Days in State
221
How long the current regime has persisted — longer means more stable
Market Data

Trading characteristics and market positioning

Beta
N/A
52W High
$28.40
37% below the year high
52W Low
$10.28
74% above the year low
Avg Volume
1,281,475
Average daily shares traded — higher means easier to buy and sell
Short Ratio
5.1
Days it would take all short sellers to cover — higher means more crowded
Short % Float
10.4%
Elevated short interest — bears are positioned against this
Div Yield
N/A
Annual dividend as a percentage of the share price
EPS (TTM)
$-0.23
Earnings per share over the last 12 months
Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity
N/A
Current Ratio
3.92
Strong balance sheet — comfortably covers short-term obligations
Quick Ratio
3.69
Like current ratio but excludes inventory — stricter test
Gross Margin
66.3%
Revenue left after cost of goods — higher means pricing power
Operating Margin
-6.1%
Profit from core operations before interest and tax
Free Cash Flow
$17M
Positive — the business generates more cash than it spends
Revenue (TTM)
$283M
Total revenue over the last 12 months
Net Income
$-6,300,000
Loss-making — spending exceeds revenue after all costs
Analyst Coverage
Analysts
12
Target High
$30.00
Target Median
$22.50
Target Low
$15.00
Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Discover More
Alpha Insights Market Intelligence Titan Watch Ethical Screener Insider Intelligence Track Record Ethical Finance Zakat Calculator Iran Oil Tracker Foundry Indicators Options Calendar Composites Boycott Tracker Is It Halal? Earnings Calendar Dividend Screener Country Guides Glossary Join Free →

Get our weekly market brief free.